相似文献
1
Human urotensin-II is a potent spasmogen of primate airway smooth muscle.
Br J Pharmacol. 2000 Sep;131(1):10-2. doi: 10.1038/sj.bjp.0703533.
2
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
Eur J Pharmacol. 2005 Jun 15;516(3):276-81. doi: 10.1016/j.ejphar.2005.04.043.
3
Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.
Br J Pharmacol. 2000 Dec;131(7):1262-74. doi: 10.1038/sj.bjp.0703690.
4
Bovine lung parenchyma strip has both airway and vascular characteristics. (Pharmacological comparisons with bronchus, pulmonary artery and vein).
Res Commun Chem Pathol Pharmacol. 1980 Jul;29(1):15-25.
5
Effect of nitric oxide on in vitro responsiveness of bovine bronchus and pulmonary vessels.
Eur Respir J. 1995 May;8(5):755-61.
6
Comparisons of reactivity of pulmonary vascular and airway smooth muscle of sheep and calf to tryptamine analogues, histamine, and antigen.
Am J Vet Res. 1975 Aug;36(08):1081-4.
7
Comparative pharmacology and antagonism of synthetic leukotrienes on airway and vascular smooth muscle.
Adv Prostaglandin Thromboxane Leukot Res. 1982;9:243-50.
8
Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery.
Regul Pept. 2004 May 15;118(3):127-34. doi: 10.1016/j.regpep.2003.11.006.
9
Tissue selectivity and spasmogen selectivity of relaxant drugs in airway and pulmonary vascular smooth muscle contracted by PGF2 alpha or endothelin.
Br J Pharmacol. 1991 Feb;102(2):311-6. doi: 10.1111/j.1476-5381.1991.tb12171.x.
10
Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
J Pharmacol Exp Ther. 1990 Mar;252(3):1318-23.
引用本文的文献
1
Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma.
Front Pharmacol. 2013 Apr 29;4:54. doi: 10.3389/fphar.2013.00054. eCollection 2013.
2
Urotensin upregulates transforming growth factor-β1 expression of asthma airway through ERK-dependent pathway.
Mol Cell Biochem. 2012 May;364(1-2):291-8. doi: 10.1007/s11010-012-1229-7. Epub 2012 Jan 21.
3
Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
Peptides. 2010 Aug;31(8):1511-6. doi: 10.1016/j.peptides.2010.04.017. Epub 2010 Apr 28.
4
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.
Br J Pharmacol. 2004 Jul;142(6):921-32. doi: 10.1038/sj.bjp.0705743. Epub 2004 Jun 21.
5
Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.
Br J Pharmacol. 2003 May;139(2):464-72. doi: 10.1038/sj.bjp.0705254.
6
Is urotensin-II the new endothelin?
Br J Pharmacol. 2002 Nov;137(5):579-88. doi: 10.1038/sj.bjp.0704924.
7
Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Br J Pharmacol. 2002 May;136(1):9-22. doi: 10.1038/sj.bjp.0704671.
8
Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.
Br J Pharmacol. 2000 Dec;131(7):1262-74. doi: 10.1038/sj.bjp.0703690.
本文引用的文献
1
Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate.
J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S163-6. doi: 10.1097/00005344-200036051-00051.
2
Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat.
Br J Pharmacol. 2000 May;130(2):201-4. doi: 10.1038/sj.bjp.0703314.
3
Urotensin II: fish neuropeptide catches orphan receptor.
Trends Pharmacol Sci. 2000 Mar;21(3):80-2. doi: 10.1016/s0165-6147(00)01449-8.
4
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Nature. 1999 Sep 16;401(6750):282-6. doi: 10.1038/45809.
5
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15803-8. doi: 10.1073/pnas.95.26.15803.
6
Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates.
J Exp Zool. 1996;275(2-3):226-38.
7
Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.
Br J Pharmacol. 1993 Nov;110(3):1175-83. doi: 10.1111/j.1476-5381.1993.tb13938.x.
8
Spasmogenic actions of frog urotensin II on the bladder and ileum of the frog, Rana catesbeiana.
Gen Comp Endocrinol. 1994 Dec;96(3):412-9. doi: 10.1006/gcen.1994.1197.
9
Complex effects of Gillichthys urotensin II on rat aortic strips.
Br J Pharmacol. 1987 May;91(1):205-12. doi: 10.1111/j.1476-5381.1987.tb09000.x.
10
Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes.
Recent Prog Horm Res. 1985;41:533-52. doi: 10.1016/b978-0-12-571141-8.50016-0.
Zotero 插件